Claudia C. Munoz
Medellin, ANT, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial.
Journal: EBioMedicine
Published: October 10, 2025
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Neurology
Published: February 07, 2025
Plasma p-tau231 in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional and longitudinal cohort study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 07, 2025
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: May 06, 2024
Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease.
Journal: Nature communications
Published: February 09, 2023
Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease.
Journal: Journal of the International Neuropsychological Society : JINS
Published: June 30, 2021
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 26, 2021
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
Journal: Journal of Alzheimer's disease : JAD
Published: September 14, 2020
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Journal: The Lancet. Neurology
Published: October 23, 2019
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 17, 2019
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registry.
Journal: Applied neuropsychology. Adult
Published: June 25, 2019
A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 25, 2018
Last Updated: 09/26/2026